Cwm LLC Has $10.77 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Cwm LLC boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 26.4% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 31,924 shares of the medical equipment provider’s stock after acquiring an additional 6,659 shares during the period. Cwm LLC’s holdings in Intuitive Surgical were worth $10,770,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Liberty Capital Management Inc. raised its holdings in Intuitive Surgical by 3.8% in the 4th quarter. Liberty Capital Management Inc. now owns 815 shares of the medical equipment provider’s stock valued at $275,000 after acquiring an additional 30 shares during the period. Miracle Mile Advisors LLC boosted its stake in shares of Intuitive Surgical by 2.3% in the fourth quarter. Miracle Mile Advisors LLC now owns 1,438 shares of the medical equipment provider’s stock valued at $485,000 after buying an additional 32 shares during the period. Ausdal Financial Partners Inc. grew its position in Intuitive Surgical by 1.5% during the fourth quarter. Ausdal Financial Partners Inc. now owns 2,192 shares of the medical equipment provider’s stock worth $739,000 after buying an additional 33 shares in the last quarter. Venturi Wealth Management LLC increased its stake in Intuitive Surgical by 10.7% during the 4th quarter. Venturi Wealth Management LLC now owns 341 shares of the medical equipment provider’s stock worth $115,000 after acquiring an additional 33 shares during the period. Finally, Modera Wealth Management LLC raised its holdings in Intuitive Surgical by 2.0% in the 3rd quarter. Modera Wealth Management LLC now owns 1,715 shares of the medical equipment provider’s stock valued at $501,000 after acquiring an additional 34 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently commented on ISRG shares. Royal Bank of Canada raised their price target on Intuitive Surgical from $400.00 to $432.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 24th. Jefferies Financial Group boosted their target price on shares of Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a research report on Friday. Raymond James upped their price target on shares of Intuitive Surgical from $372.00 to $435.00 and gave the stock an “outperform” rating in a report on Thursday, January 25th. Piper Sandler lifted their price objective on shares of Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a research note on Friday. Finally, Truist Financial raised their target price on Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a report on Wednesday, January 24th. Five research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $396.17.

Insider Buying and Selling

In other news, EVP Myriam Curet sold 4,318 shares of the firm’s stock in a transaction dated Friday, January 26th. The stock was sold at an average price of $370.15, for a total value of $1,598,307.70. Following the completion of the sale, the executive vice president now directly owns 189 shares in the company, valued at approximately $69,958.35. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other Intuitive Surgical news, EVP Myriam Curet sold 4,318 shares of the company’s stock in a transaction dated Friday, January 26th. The shares were sold at an average price of $370.15, for a total value of $1,598,307.70. Following the completion of the sale, the executive vice president now directly owns 189 shares of the company’s stock, valued at approximately $69,958.35. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Alan J. Levy sold 2,000 shares of Intuitive Surgical stock in a transaction that occurred on Friday, January 26th. The stock was sold at an average price of $370.20, for a total transaction of $740,400.00. Following the transaction, the director now directly owns 25,319 shares in the company, valued at approximately $9,373,093.80. The disclosure for this sale can be found here. Insiders have sold a total of 248,418 shares of company stock valued at $95,927,097 over the last ninety days. 0.80% of the stock is owned by corporate insiders.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $368.93 on Tuesday. The stock has a market capitalization of $130.77 billion, a PE ratio of 66.59, a PEG ratio of 5.69 and a beta of 1.36. The business’s 50 day simple moving average is $386.57 and its 200 day simple moving average is $344.41. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.10. The company had revenue of $1.89 billion during the quarter, compared to analysts’ expectations of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. Intuitive Surgical’s revenue for the quarter was up 11.5% compared to the same quarter last year. During the same period in the prior year, the company posted $1.00 earnings per share. As a group, research analysts expect that Intuitive Surgical, Inc. will post 4.93 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.